Revance Therapeutics Inc (RVNC) volume exceeds 1.45 million: A new investment opportunity for investors
On Monday, Revance Therapeutics Inc (NASDAQ: RVNC) was -4.52% down from the session before settling in for the closing price of $4.87. A 52-week range